D.E. Shaw & Co
RPTP

D.E. Shaw & Co’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

D.E. Shaw & Co’s Portfolio RPTP Stock Details RPTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-50,000
Closed -$790K – 4135
2015
Q2 		$790K Buy
+50,000
New +$607K ﹤0.01% 2868

D.E. Shaw & Co's RPTP Position: Q4 2016 in Review

D.E. Shaw & Co sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q4 2016, closing a stake of 931,488 shares — an estimated $8.36M sold.

D.E. Shaw & Co first reported a position in RPTP in Q3 2013 and held it in 13 quarters. The position peaked at $35.2M in Q2 2015. 0 funds tracked by Wall St. Rank hold RPTP as of Q4 2016.

  • D.E. Shaw & Co reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q4 2016 after selling out during the quarter.
  • D.E. Shaw & Co sold 931,488 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q4 2016, an estimated $8.36M.
  • D.E. Shaw & Co first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q3 2013 and held it in 13 quarters.
  • D.E. Shaw & Co's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $35.2M in Q2 2015.
  • 0 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q4 2016.

Based on D.E. Shaw & Co's 13F filing for Q4 2016, filed 14 Feb 2017.